Bernstein upgraded Novo Nordisk (NVO) to Outperform from Market Perform.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- ICER update on GLP-1s a ‘win’ for Eli Lilly, says BofA
- Hims Stock (HIMS) Rises as FDA Publishes “Green List,” Novo Nordisk Shares Slip
- Posse of U.S. Law Firms Saddles Up for Court Showdown with Novo Nordisk (NVO)
- HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat
- Quantum Software Stocks Surge as Real-World Deals and Revenue Potential Drive Investors’ Attention